|
|
||||||||
a Department of Surgery, Fletcher Allen Health Care/University of Vermont, Burlington, Vermont
b Division of Cardiothoracic Surgery, Fletcher Allen Health Care/University of Vermont, Burlington, Vermont
c Department of Pathology, Fletcher Allen Health Care/University of Vermont, Burlington, Vermont
d Department of Surgery, Division of Surgical Oncology, Fletcher Allen Health Care/University of Vermont, Burlington, Vermont
Accepted for publication March 21, 2008.
* Address correspondence to Dr Privette, Fletcher Allen Health Care/University of Vermont (FAHC/UVM), Department of Surgery, 111 Colchester Ave, Burlington, VT 05401 (Email: alicia.privette{at}vtmednet.org).
Inflammatory myofibroblastic tumor is a rare neoplasm of intermediate malignant potential. Although inflammatory myofibroblastic tumor occurs at multiple anatomic locations, an esophageal lesion is extremely rare. We describe a 43-year-old man who presented with severe dysphagia and an inflammatory syndrome, secondary to esophageal inflammatory myofibroblastic tumor. The patient was treated successfully with esophagectomy and remains disease free at 1 year. This case illustrates the complexities involved in managing a large esophageal myofibroblastic tumor and highlights that esophagectomy, rather than enucleation, should be the treatment of choice.
This article has been cited by other articles:
![]() |
S. C. Chow, A. Nahal, S. Mayrand, and L. E. Ferri Pulmonary Inflammatory Myofibroblastic Tumor Invading the Gastroesophageal Junction Ann. Thorac. Surg., May 1, 2010; 89(5): 1659 - 1661. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |